All news (page 50)

8 June 2026

GRILLO continues groundwater investigations at Willy‑Brandt‑Ring

Extended short‑ and long‑term pumping tests will refine subsoil hydraulic data, measure ochre (iron) precipitation and monitor water quality to support design of an on‑site containment well system.
8 June 2026

SABIC wins R&D 100 for laser‑weldable NORYL V0 resins

First‑of‑its‑kind laser‑weldable resins for solar PV enable faster, cleaner microinverter manufacturing with flame retardancy, improved weatherability and lower waste.
8 June 2026

Gas Malaysia, Tokyo Gas and VTTI to develop 6 MTPA FSRU regasification terminal in Yan, Kedah

Offshore FSRU regasification terminal proposed off Pulau Bunting to add an LNG entry point in northern Peninsular Malaysia; capacity up to 6 MTPA and estimated cost RM2–3bn; project advancing toward FID.
8 June 2026

Honeywell reaffirms 2026 guidance and issues Honeywell Technologies outlook

Full-year sales $38.8–39.8B; adjusted EPS $10.35–10.65 and free cash flow $5.3–5.6B. Post-spin Honeywell Technologies sales $19.9–20.2B; adjusted EPS $3.95–4.15.
8 June 2026

Honeywell expands OT Cybersecurity Suite with AI monitoring and secure media controls

Adds five OT security capabilities — AI monitoring, secure media scanning, data diode, Cyber GRC automation and a managed OT SOC — for manufacturing, energy and critical infrastructure.
8 June 2026

Braskem brings IG4 and Petrobras into governance and names new executive team

Governance refreshed to accelerate financial reorganisation, improve operational efficiency and preserve liquidity; new CEO and turnaround-focused leadership appointed.
8 June 2026

Uniper and Ksi Lisims LNG sign LOI for 2 mtpa Canadian LNG supply

LOI outlines a 2 mtpa long-term LNG purchase, with first volumes possible in 2032 from a proposed 12 mtpa BC floating export facility designed for low emissions.
8 June 2026

Lilly's Foundayo (orforglipron) outperforms oral semaglutide, dapagliflozin and placebo in ACHIEVE trials

Oral GLP‑1 orforglipron reduced A1C and body weight more than oral semaglutide, dapagliflozin or placebo across three Phase‑3 trials; FDA filing planned by end of Q2 2026.
8 June 2026

Gilead and Merck: Phase 3 ISLEND trials show positive topline results for once‑weekly islatravir/lenacapavir

Once‑weekly oral islatravir 2 mg/lenacapavir 300 mg met Week 48 primary endpoint, non‑inferior to Biktarvy and daily standard‑of‑care; safety profile comparable across arms.
8 June 2026

Merck and Gilead discontinue Phase 3 KEYNOTE‑D46/EVOKE‑03 (Trodelvy + KEYTRUDA) in PD‑L1 ≥50% mNSCLC

eDMC recommended stopping the Phase 3 trial after final PFS and interim OS reviews: PFS trend non‑significant, OS unlikely to be significant; safety profile consistent; ~620 patients enrolled.
8 June 2026

Meccanoplastica showcases INEOS recycled HDPE at PLAST 2026

Live blow-moulding demo will produce 200ml cosmetic bottles with advanced recycled HDPE; 4L samples use Recycl-IN HDPE with 50% post‑consumer recyclate to support regulatory targets.
8 June 2026

Equinor ASA elects Jarle Roth as board chair

Jarle Roth named chair; deputy and several board members re-elected; new board term runs 1 July 2026 to June 2027.
8 June 2026

Iberdrola (Neoenergia) to invest €4.5bn in Bahia power networks to 2030

Nearly €4.5bn (25bn reais) planned for Bahia to 2030 to expand, modernise and digitalise networks and connect new industries with 54 substations and extensive HV/MV lines.
8 June 2026

PPG appoints John Smith VP, Architectural Coatings EMEA; Steve Pocock to retire

John Smith will lead EMEA architectural coatings from July 1, 2026; Steve Pocock retires June 30, 2026.
8 June 2026

Johnson & Johnson to acquire Firefly Bio for $1 billion to add Firelink DAC platform

Targets KRAS-driven solid tumours with a selective protein degrader; closing expected later this year pending regulatory approvals.
8 June 2026

WACKER: ceramifying silicone and 1.6/2.4 W/mK potting compounds for BEV thermal protection

Ceramifying silicone boosts thermal and flame resistance in battery barriers; potting compounds deliver 1.6 and 2.4 W/mK, low sedimentation and room‑temperature cure.
8 June 2026

PETRONAS and Eni form Searah JV to boost regional energy security

50:50 JV combines 19 gas assets across Malaysia and Indonesia, targets 300k→500k boe/d and plans $20bn investment backed by a $6bn credit facility.
8 June 2026

Siemens and Infineon partner to add CoolSiC SiC modules to SENTRON 3QD2 breakers

SiC power modules boost semiconductor circuit breakers for faster, denser, more reliable protection in data centers, factories and battery storage.
8 June 2026

Technip Energies wins EPCIC contract for Coral Norte FLNG with JGC and Samsung Heavy

Coral Norte FLNG will produce ~3.6 Mtpa, doubling the Coral hub to 7 Mtpa and placing Mozambique among Africa’s top three LNG producers.
8 June 2026

ORLEN launches small‑scale LNG and bioLNG market demand survey

Survey collects customer forecasts on volumes, delivery points and fuel-use models to shape future small‑scale LNG/bioLNG infrastructure and commercial offers; open until end of June.
8 June 2026

Aurubis Italia first site in Italy awarded The Copper Mark

Avellino rod plant becomes first in Italy to gain The Copper Mark, completing certification of all four rod plants and expanding verified coverage across the group's production network.
8 June 2026

BASF launches Oppanol® N PLUS binder for next‑generation EV batteries

High‑spec polyisobutene binder for solid‑state and advanced EV batteries; narrow specs reduce production variability; fresh stock and 20 kg packaging support OEMs.
8 June 2026

Kemira: Nomination Board members named

Four largest shareholders — Oras Invest, Varma, Ilmarinen and Nordea Funds — appoint representatives to the Nomination Board; Board Chair serves as expert member.
8 June 2026

Roche and Nurix partner to co-develop and co-commercialise BTK degrader bexobrutideg

Collaboration targets B‑cell malignancies, immunology and neurology with an oral, brain‑penetrant BTK degrader planned for Phase 3 in summer 2026.
8 June 2026

AGC Biologics to develop and manufacture KTP-001 (rhMMP-7) for Teikoku Pharma

Microbial process development and GMP clinical manufacturing of rhMMP‑7 for intradiscal injection; cell bank moved from Heidelberg to Chiba; intended as a lumbar disc herniation treatment.
7 June 2026

Boehringer Ingelheim: Survodutide Phase III shows up to 34% visceral and 63% liver fat reduction with limited lean mass loss

Phase III data show targeted visceral and liver fat reductions with minimal lean mass loss and sustained weight loss in obesity and MASLD populations.
7 June 2026

Novo Nordisk CagriSema Phase 3 trials show large HbA1c and weight reductions

Once‑weekly cagrilintide+semaglutide reduced HbA1c by up to 2.33 percentage points and bodyweight by up to 14.2% across REIMAGINE 1–3 versus comparators.
7 June 2026

Lilly Foundayo shows weight loss across pre-, peri- and post‑menopause

Orforglipron produced meaningful body‑weight and waist reductions across menopausal stages in ATTAIN‑1 and ATTAIN‑2, including women with type 2 diabetes.
7 June 2026

Amgen: Repatha (evolocumab) cuts first major CV events 29% in high‑risk diabetes subgroup

VESALIUS‑CV subgroup shows evolocumab lowers first major cardiovascular events and LDL‑C; real‑world GLP‑1 persistence is low, curbing potential benefits.
6 June 2026

MOL secures OFAC licence to continue NIS acquisition talks

US licence allows continuation of talks to buy a majority stake in a Serbian oil company until 16 June 2026, enabling finalisation of transaction documentation.

← Previous Next →